Health Encyclopedia

Nasalide

Nasalide: Uses, Side Effects, Dosage & Reviews

Introduction to Nasalide (Flunisolide)

Nasalide is a non-aerosol nasal spray containing the active ingredient flunisolide, a corticosteroid used to prevent and treat seasonal and year-round allergy symptoms such as stuffy nose, runny nose, itchy nose, eyes, and throat, and sneezing. It works by decreasing inflammation in the nasal passages, providing effective relief from nasal congestion and other allergic rhinitis symptoms.

Chemical Composition and Properties

Flunisolide, the active ingredient in Nasalide, is a synthetic corticosteroid with the chemical formula C 24H 31FO 6. It has a molecular weight of 434.5 g/mol and a CID of 3379. Flunisolide is a white to off-white crystalline powder that is practically insoluble in water but soluble in organic solvents such as ethanol and acetone.

Research papers on the chemical properties of flunisolide:

Mechanism of Action

Flunisolide, like other corticosteroids, works by binding to glucocorticoid receptors in the cytoplasm of cells. This complex then translocates to the nucleus, where it regulates the transcription of various genes involved in the inflammatory response. By suppressing the production of pro-inflammatory mediators such as histamine, leukotrienes, and prostaglandins, flunisolide reduces inflammation in the nasal passages, thereby alleviating allergy symptoms.

Research papers on the mechanism of action of flunisolide:

Uses of Nasalide

Nasalide is primarily used for the treatment of seasonal and year-round allergy symptoms, such as:

It is particularly effective in treating allergic rhinitis, also known as hay fever, which is caused by airborne allergens such as pollen, dust mites, and pet dander.

Research papers on the uses of flunisolide:

Dosage and Administration

The recommended starting dosage of Nasalide for adults and children 6 years of age and older is two sprays (58 mcg) in each nostril twice daily (total dose, 232 mcg per day). In some patients, the dosage may be reduced to one spray in each nostril twice daily (total dose, 116 mcg per day) for maintenance therapy.

To administer Nasalide:

  1. Shake the bottle well before each use.
  2. Remove the dust cover and the safety clip.
  3. Prime the pump if it is the first use or if the pump hasn’t been used for a week or more.
  4. Gently blow your nose to clear the nostrils.
  5. Tilt your head forward slightly and insert the nasal applicator into one nostril.
  6. Close the other nostril with your finger and breathe in through your nose as you pump the spray.
  7. Breathe out through your mouth.
  8. Repeat the process for the other nostril.
  9. Wipe the nasal applicator with a clean tissue and replace the dust cover and safety clip.

Side Effects

Common side effects of Nasalide include:

Severe side effects are rare but may include:

Long-term use of Nasalide may lead to an increased risk of cataracts, glaucoma, or nasal septal perforation. Regular monitoring by a healthcare professional is recommended.

Research papers on the side effects of flunisolide:

Warnings and Precautions

Nasalide should not be used in patients with a known hypersensitivity to flunisolide or any of the ingredients in the nasal spray. It should be used with caution in patients with recent nasal ulcers, nasal surgery, or nasal trauma, as well as in those with active or quiescent tuberculosis, untreated fungal, bacterial, or viral infections, or ocular herpes simplex.

Pregnant women should use Nasalide only if the potential benefit justifies the potential risk to the fetus. It is not known whether flunisolide is excreted in human milk, so caution should be exercised when administering the drug to nursing women.

Nasalide may interact with other medications, such as ketoconazole, ritonavir, and itraconazole. Patients should inform their healthcare provider about all the medicines they take before starting treatment with Nasalide.

Comparative Analysis

Nasalide belongs to the class of intranasal corticosteroids, which includes other medications such as beclomethasone, budesonide, ciclesonide, fluticasone, mometasone, and triamcinolone. While all these drugs are effective in treating allergic rhinitis, they may differ in terms of potency, onset of action, and side effect profile.

Compared to oral antihistamines and decongestants, intranasal corticosteroids like Nasalide provide better relief of nasal symptoms and have a lower risk of systemic side effects. However, they may cause local side effects such as nasal irritation and nosebleeds.

Research papers comparing flunisolide with other treatments:

User Reviews and Experiences

Many users report significant relief from their allergy symptoms after using Nasalide. They appreciate the non-drowsy formula and the convenience of a nasal spray. Some users experience mild side effects such as nasal irritation or nosebleeds, but these are usually transient and well-tolerated.

Here are some examples of user reviews:

Clinical Studies and Research

Several clinical studies have demonstrated the efficacy and safety of flunisolide nasal spray in the treatment of allergic rhinitis. A randomized, double-blind, placebo-controlled trial involving 477 patients with seasonal allergic rhinitis found that flunisolide nasal spray significantly reduced nasal symptoms compared to placebo, with a favorable safety profile.

Another study comparing flunisolide with beclomethasone dipropionate in patients with perennial allergic rhinitis showed that both treatments were equally effective in reducing nasal symptoms, with a similar incidence of adverse events.

Research papers on clinical studies of flunisolide:

Prescription and Availability

Nasalide is a prescription medication available in the United States and several other countries. It can be obtained through a prescription from a licensed healthcare provider, such as a primary care physician, allergist, or otolaryngologist.

Nasalide is sold under different brand names, depending on the region:

Cost and Savings

The cost of Nasalide varies depending on the pharmacy, location, and insurance coverage. On average, a 25 g bottle (120 sprays) of Nasalide costs between $100 and $200 without insurance. However, many insurance plans cover Nasalide, and patients may be able to obtain the medication with a copay of $10 to $50.

Patients can save money on Nasalide by:

Pharmacokinetics and Pharmacodynamics

After intranasal administration, flunisolide is rapidly absorbed through the nasal mucosa, with a bioavailability of approximately 50%. Peak plasma concentrations are reached within 1 to 2 hours after dosing. Flunisolide is extensively metabolized by the liver, primarily via the cytochrome P450 3A4 enzyme system, and has a half-life of about 1 to 2 hours.

The pharmacodynamic effects of flunisolide are mediated through its binding to glucocorticoid receptors, which results in the modulation of gene expression and the suppression of inflammatory mediators. The onset of action of flunisolide nasal spray is generally within 1 to 2 days, with maximum benefit achieved after 2 to 4 weeks of regular use.

Research papers on the pharmacokinetics and pharmacodynamics of flunisolide:

Contraindications and Risks

Nasalide is contraindicated in patients with a known hypersensitivity to flunisolide or any of the ingredients in the nasal spray. It should not be used to treat nasal polyps or acute asthma attacks.

Long

Nasalide